Trademark Search  /  PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

○ Dead · Abandoned

U.S. federal trademark · Serial No. 77741348

Mark
PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES
Status
Abandoned
Serial Number
77741348
Filing Date
May 20, 2009
Class(es)
Class 042

Owner

Bristol-Myers Squibb Company
03 · New York, NY, US

Goods & Services

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.